Implications of New Anticoagulants in Primary Practice
00:00 EST 1 Feb 2013 | Medscape
This review discusses the characteristics of the three new oral anticoagulants rivaroxaban, apixaban, and dabigatran, and their implications for both treatment and prevention in primary care. International Journal of Clinical Practice
Original Article: Implications of New Anticoagulants in Primary Practice
More From BioPortfolio on "Implications of New Anticoagulants in Primary Practice"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
